248 related articles for article (PubMed ID: 29410160)
1. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS
Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160
[TBL] [Abstract][Full Text] [Related]
2. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
[TBL] [Abstract][Full Text] [Related]
3. Impact of γ'γ' fibrinogen interaction with red blood cells on fibrin clots.
Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Sabban A; Martins IC; Duval C; Santos NC; Ariëns RA
Nanomedicine (Lond); 2018 Oct; 13(19):2491-2505. PubMed ID: 30311540
[TBL] [Abstract][Full Text] [Related]
4. Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing.
Domingues MM; Macrae FL; Duval C; McPherson HR; Bridge KI; Ajjan RA; Ridger VC; Connell SD; Philippou H; Ariëns RA
Blood; 2016 Jan; 127(4):487-95. PubMed ID: 26608329
[TBL] [Abstract][Full Text] [Related]
5. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.
Collet JP; Nagaswami C; Farrell DH; Montalescot G; Weisel JW
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):382-6. PubMed ID: 14656741
[TBL] [Abstract][Full Text] [Related]
6. Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure.
Cantero M; Rojas H; Anglés-Cano E; Marchi R
BMC Mol Cell Biol; 2019 Nov; 20(1):47. PubMed ID: 31675913
[TBL] [Abstract][Full Text] [Related]
7. The presence of gamma' chain impairs fibrin polymerization.
Gersh KC; Nagaswami C; Weisel JW; Lord ST
Thromb Res; 2009 Jul; 124(3):356-63. PubMed ID: 19138790
[TBL] [Abstract][Full Text] [Related]
8. Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans.
Pieters M; Kotze RC; Jerling JC; Kruger A; Ariëns RA
Blood; 2013 Apr; 121(16):3254-60. PubMed ID: 23422752
[TBL] [Abstract][Full Text] [Related]
9. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
Falls LA; Farrell DH
J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
[TBL] [Abstract][Full Text] [Related]
10. High fibrinogen γ' levels in patient plasma increase clot formation at arterial and venous shear.
Macrae FL; Swieringa F; Heemskerk JWM; Ariëns RAS
Blood Adv; 2021 Sep; 5(17):3468-3477. PubMed ID: 34438442
[TBL] [Abstract][Full Text] [Related]
11. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot.
Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW
Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
[TBL] [Abstract][Full Text] [Related]
14. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
[TBL] [Abstract][Full Text] [Related]
15. Structure of fibrin network of two abnormal fibrinogens with mutations in the αC domain on the human dermal microvascular endothelial cells 1.
Marchi R; Rojas H; Castillo O; Kanzler D
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):706-11. PubMed ID: 21986467
[TBL] [Abstract][Full Text] [Related]
16. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers.
Langer BG; Weisel JW; Dinauer PA; Nagaswami C; Bell WR
J Biol Chem; 1988 Oct; 263(29):15056-63. PubMed ID: 3170575
[TBL] [Abstract][Full Text] [Related]
17. Lytic resistance of fibrin containing red blood cells.
Wohner N; Sótonyi P; Machovich R; Szabó L; Tenekedjiev K; Silva MM; Longstaff C; Kolev K
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2306-13. PubMed ID: 21737785
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.
Cooper AV; Standeven KF; Ariëns RA
Blood; 2003 Jul; 102(2):535-40. PubMed ID: 12663453
[TBL] [Abstract][Full Text] [Related]
19. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes.
Gersh KC; Nagaswami C; Weisel JW
Thromb Haemost; 2009 Dec; 102(6):1169-75. PubMed ID: 19967148
[TBL] [Abstract][Full Text] [Related]
20. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
